Can we rely on out-of-hospital blood samples? A prospective interventional study on the pre-analytical stability of blood samples under prehospital emergency medicine conditions by Prottengeier, Johannes et al.
ORIGINAL RESEARCH Open Access
Can we rely on out-of-hospital blood
samples? A prospective interventional
study on the pre-analytical stability of
blood samples under prehospital
emergency medicine conditions
Johannes Prottengeier1* , Nicola Jess2, Frank Harig3, Christine Gall4, Joachim Schmidt1 and Torsten Birkholz1
Abstract
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergency patient
at the earliest possible moment in the course of acute illness and in a state prior to therapeutic interventions. Our
study investigates the pre-analytical stability of biomarkers in prehospital emergency medicine and will answer the
question whether an approach of blood sampling out in the field will deliver valid laboratory results.
Methods: We prepared pairs of blood samples from healthy volunteers and volunteering patients post
cardio-thoracic surgery. While one sample set was analysed immediately, the other one was subjected to a
worse-than-reality treatment of 60 min time-lapse and standardized mechanical forces outside of the hospital
through actual ambulance transport. We investigated 21 parameters comprising blood cells, coagulation tests,
electrolytes, markers of haemolysis and markers of cardiac ischemia. Bland-Altman analysis was used to investigate
differences between test groups. Differences between test groups were set against the official margins of test
accuracy as given by the German Requirements for Quality Assurance of Medical Laboratory Examinations.
Results: Agreement between immediate analysis and our prehospital treatment is high as demonstrated by
Bland-Altman plotting. Mechanical stress and time delay do not produce a systematic bias but only random
inaccuracy. The limits of agreement for the tested parameters are generally within clinically acceptable ranges of
variation and within the official margins as set by the German Requirements for Quality Assurance of Medical
Laboratory Examinations.
Discussion: We subjected blood samples to a standardized treatment marking a worse-than-reality scenario of
prehospital time delay and transport. Biomarkers including indicators of myocardial ischemia showed high
pre-analytical stability.
Conclusion: We conclude the validity of blood samples from a prehospital environment.
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Background
Laboratory tests from blood samples are a major
component in the diagnostic work-up of emergency pa-
tients [1, 2]. Usually the required blood samples are
drawn inside the emergency department (ED) and there
is a general consensus, that samples should be analysed
as soon as possible and handled carefully [3–5]. When-
ever a patient is being cared for by emergency medical
services (EMS) prior to his admission to the ED, there
arises an opportunity and unsolved question at the same
time: EMS will frequently establish venous access [6, 7].
This could very well be utilized to secure blood speci-
mens back-to-back to a patient’s first contact with med-
ical help. Firstly, such samples would produce results
representative of the patient’s condition before any inter-
vention: before infusion of fluids and haemodilution, be-
fore heparin and anticoagulation, before diuretics and
changes to electrolytes – to mention a few iatrogenic al-
terations. Secondly they would provide additional insight
into the course of dynamic biomarkers in scenarios such
as myocardial infarction [8]. And finally, prehospital
sampling may save time in the diagnostic process as time
consumption for blood sampling adjacent to the process
of venous cannulation may be smaller than a second
procedure performed inside the ED, especially consider-
ing the inversion of the patient-staff ratio from the
prehospital to the intrahospital setting.
But are those presumed advantages real? Up to date
no data exists to evaluate the clinical value of prehospital
blood sampling. Even less, literature provides no answer
to the more basic question, whether those laboratory
values relevant to emergency medicine show the neces-
sary preanalytical stability to allow for reliable testing–if
they were gathered in a prehospital setting.
The aim of our study was to subject blood samples to
a standardized “worst-case-scenario” prehospital treat-
ment of mechanical forces and time delay before labora-
tory testing. We investigated the preanalytical stability of
biomarkers frequently used in emergency diagnostics
compared to an immediate analysis. This included myo-
cardial enzymes, complete blood counts and tests of
haemostasis, haemolysis, electrolytes and different pro-
teins. Owing to its key role in the work-up of “chest-
pain” we focused on the changes of troponin levels as
our primary parameter of interest.
Methods
Blood donors
This study was approved by the ethics board of the
University of Erlangen-Nuremberg. Blood sampling took
place at the Erlangen University Hospital. Samples where
provided by healthy volunteers (physicians, nurses, para-
medics) and volunteering scheduled patients post major
cardio-thoracic surgery. All volunteers gave their
informed consent well before the investigations. The
composition of our study population guaranteed that
biomarkers covered a wide range of values from physio-
logical (in healthy volunteers) to highly pathological (e.g.
elevated cardiac enzymes in patients post cardiotomy).
Blood sampling
All samples were collected under standardized, stringently
timed conditions and adherence to the syringe manufac-
turers’ product manuals and the hospital’s standard oper-
ating procedures of hygiene and safety. Only venous blood
was obtained. Specimens for blood gas analysis were con-
tained in “safePico Aspirators” (Radiometer Medical ApS,
Brønshøj, Denmark) and all other specimen in “S-Monov-
ettes” (Sarstedt AG, Nümbrecht, Germany). Table 1 shows
the allocation of parameters to their specific syringe. Ana-
lysis took place in the University Hospital’s laboratories
with the exception of blood gas analyses, which were per-
formed on the Department of Anaesthesia’s own ABL
800Flex analysers (Radiometer Medical ApS, Brønshøj,
Denmark). Table 2 provides an overview of analysers, ana-
lytical methods and legally required analytical accuracy for
each parameter.
Table 1 List of parameters and sample syringes
Type of syringe S-Monovette/red
Haematology
S-Monovette/green
Coagulation profile
S-Monovette/white
Clotting Activator/Serum
S-Monovette/orange
Lithium Heparin/Serum
safePICO Aspirator
Blood-Gas-Analysis
Additive Potassium-EDTA Citrate Clotting Activator Lithium Heparin 80 IU Heparin
Parameters (alphabetic order)
of laboratory testing
Haemoglobin Antithrombin III Alpha-HBDH Alpha-HBDH Calcium/Ca++
Leukocytes Activated Partial
Thromboplastin Time (aPTT)
Creatinine Creatinine Chloride/Cl-
Thrombocytes Fibrinogen Creatin Kinase/CK Creatin Kinase/CK Potassium/K+
International Normalized
Ratio (INR)
Free Haemoglobin Free Haemoglobin Sodium/Na+
Glutamic Oxaloacetic
Transaminase
Glutamic Oxaloacetic
Transaminase
Troponin I
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We generated two equal sets of syringes from every
volunteer. Parameters can be divided in two groups:
Group 1 represents a shortlist of biomarkers highly rele-
vant to emergency medicine. Group 2 (items in italics in
Table 1) represent markers of haemolysis which may
falsify other test procedures.
Each set of samples was allotted to one of two differ-
ent treatment conditions.
Control Group (CG)
All specimen were immediately transported to analysis
by foot within 10 min of sampling. All specimens were
subject to room temperature as provided by the
hospital’s climate control system.
Prehospital Group (PHG)
Samples were analysed after a time lapse of 60 min during
which they underwent a standardized scenario of mechan-
ical stress (see below). During transport all samples were
kept lying flat in a cooler box (Coleman Inc., Wichita,
United States) tempered to the intensive care unit’s 23 °C
standard room temperature, which is maintained by a cli-
mate control system. Temperature of the test compart-
ment was monitored end-to-end and samples were not
subject to external heating or cooling. By these means of
storage, samples were also shielded from solar radiation.
Prehospital scenario
Samples allotted to the PHG were transferred to an ambu-
lance truck (1998 Sprinter, Model 312 D, Mercedes Benz,
Stuttgart, Germany. It was the oldest and most worn
down model available from local emergency services at
that time.). The Cooler Box was placed on the worktop in-
side the patient’s cabin. Samples were sent onto a 15 km
and 30 min long drive in and around the city of Erlangen,
which consisted of city traffic, dirt tracks and larger state
roads. Driving mode (gear), velocity, and thus time con-
sumption and the quantity of mechanical forces were
standardized through a dedicated driving protocol. The
reproducibility of mechanical forces was evaluated in pre-
test trials using a Triaxial Vibration Meter VM30-H
(Metra Mess- und Frequenztechnik, Radebeul, Germany)
placed in the site of the syringes.
Under the infrastructural and geographic circumstances
of German EMS, pre-hospital time requirements shall not
exceed 60 min. This time frame has originated from the
“golden hour of shock” and has been adopted for time-
sensitive diagnoses such as multiple trauma, traumatic
brain injury, stroke, sepsis, chest-pain and resuscitation. It
is the upper limit for the pre-hospital phase of emergency
care in Germany and is one of the main determinants for
the allocation of EMS resources [9].
In context of these circumstances, our prehospital set-
up represented a worst-case scenario by far longer in
duration and far more mechanically straining than average
missions found in land-based EMS in Germany [10–13].
Data analysis and statistics
To analyse the effect of mechanical stress and time on
blood samples, we use Bland-Altman plots to compare
the measurements with the reference blood samples
which were analysed immediately [14].
The solid line in the graph shows the mean of the dif-
ferences. The dashed upper (lower) line shows the upper
(lower) limit of agreement equal to mean ± 2SD. Within
these limits, typically lie 95% of the samples differences.
The dotted lines represent the respective 95% confidence
intervals. As external margins for negligible differences,
we use the relative differences specified for certain
ranges of validity given by the Guidelines of the German
Medical Association on quality assurance in medical la-
boratory testing (Rili-BAEK) [15]. The Rili-BAEK is the
official benchmarking guideline of German medical la-
boratories. The validity of test results is strictly limited
by predefined margins of error. Therefore we postulate
that results must be considered as equal, should their
differences lie within the set margins of the Rili-BAEK.
Comparing Bland-Altman plots for absolute and rela-
tive differences confirmed our choice of absolute differ-
ences as then the points better fit the horizontal limits
of agreement along the range of the x-axis. Thus, the
tolerated difference given by Rili-BAEK [15] is not con-
stant over x but shown by sloping lines.
Analyses were performed in R 3.2.4 [R Core Team
(2013). R: A language and environment for statistical
computing. R Foundation for Statistical Computing,
Vienna, Austria. URL http://www.R-project.org/].
Results
We prepared 134 sample sets and selected 21 bio-
markers for Bland-Altman analysis (Table 3). Factors
such as analyser malfunction, treatment against protocol
(dropping of syringes, inadequate filling heights etc.) led
to the exclusion of some samples. The number of
complete data sets for each parameter is documented.
The effect of our prehospital scenario compared to im-
mediate testing is demonstrated by the Bland-Altman
plots of each parameter. We present in this manuscript
a selection of plots in Figs. 1, 2, 3, 4, 5 and 6. Plots for 8
other analysed parameters can be found as Additional
files 1, 2, 3, 4, 5, 6, 7 and 8 (Figures S7–S14). Table 3
provides a comprehensive overview of each parameter,
means of differences, standard deviations and confidence
intervals between Groups CG and PHG. The estimated
means of differences are always negligible with a small
95%-CI, i.e. mechanical stress does not produce a sys-
tematic bias but only random inaccuracy. The limits of
agreement are universally within clinically acceptable
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Fig. 1 Troponin I (Unit: ng/dl)–One outlying sample pair has been
excluded from the plot for reasons of better graphical display (Native:
36.82; Mechanic: 37.22). Bland-Altman plots for selected biomarkers.
The difference in measurements is plotted against the average value of
both associated measurements. The margins of accuracy as given by
the Rili-BAEK are drawn as sloping lines. Agreement is high. Variations
are random and no systemical bias through treatment can be detected.
Inaccuracy is well within the limits of the Rili-BAEK and within tolerance
of clinical interpretation
Fig. 3 Thrombocytes (Unit: 109/l). Bland-Altman plots for selected
biomarkers. The difference in measurements is plotted against the
average value of both associated measurements. The margins of
accuracy as given by the Rili-BAEK are drawn as sloping lines.
Agreement is high. Variations are random and no systemical bias
through treatment can be detected. Inaccuracy is well within the
limits of the Rili-BAEK and within tolerance of clinical interpretation
Fig. 2 Haemoglobin (Unit: g/dl). Bland-Altman plots for selected
biomarkers. The difference in measurements is plotted against the
average value of both associated measurements. The margins of
accuracy as given by the Rili-BAEK are drawn as sloping lines.
Agreement is high. Variations are random and no systemical bias
through treatment can be detected. Inaccuracy is well within the
limits of the Rili-BAEK and within tolerance of clinical interpretation
Fig. 4 Activated Partial Thromboplastin Time – aPTT (Unit: sec.).
Bland-Altman plots for selected biomarkers. The difference in
measurements is plotted against the average value of both associated
measurements. The margins of accuracy as given by the Rili-BAEK are
drawn as sloping lines. Agreement is high. Variations are random and
no systemical bias through treatment can be detected. Inaccuracy is
well within the limits of the Rili-BAEK and within tolerance of clinical
interpretation
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ranges of variation. Alterations are mostly within the offi-
cial margin of accuracy as set by the Rili-BAEK. Troponin
I showed comparable results when compared between im-
mediate analysis and analysis after the combination of
time delay and mechanical stress. Among the 134 sam-
ples, 47/134 = 35% of the troponin values lie within the
interval from 0.1 to 35 ng/dl which is the range addressed
by the Rili-BAEK. Only for two samples, the relative dif-
ference was more than 0.2 ng/dl, precisely 0.3 and
0.21 ng/dl. For 15 (=15/47 = 32%) of these 47 values, there
was no measurable difference at all, i.e. the measurement
after prehospital treatment was exactly like the immedi-
ately analysed one. For the rest of the values, the relative
difference was less or equal to 0.15 ng/dl. Thus, for 45/47
= 95,7% (CI [89.97%; 100%]) of the samples, the relative
difference is easily acceptable. For 87/134 = 65% of the
samples, the troponin measurements are lower than
0.1 ng/dl. For 78 (=89.655%, CI = [83.256%; 96.1%]) sam-
ples, the deviation is Zero or less than the technical cap-
abilities of measurement, respectively. For seven samples,
the absolute differences are equal to 0.01 ng/dl. For the
remaining two samples, they are 0.04 and 0.4 ng/dl.
Haemolysis as a potent interference factor with many
chromage laboratory tests was investigated and excluded
in relevant levels by investigations into alpha-HBDH and
free haemoglobin in serum (Fig. 6 and Additional files 6,
7 and 8: Figures S12–S14).
Discussion
Emergency services regularly represent the first line of
contact between medical care and patients. In many
cases, circumstances would allow for the sampling of
blood in the early stages of acute illness. While it is con-
ceivable that such an approach might have clinical bene-
fits, there is little data to proof the pre-analytical validity
of biomarkers achieved this way. In our study we simu-
lated the prehospital fate of blood samples and investi-
gated changes to test results when compared to
immediate analysis. We improvised a combination of
time delay and mechanical stress that resulted in a sam-
ple exposition worse than what would be expected in
German EMS on a regular basis.
We found that our exposition of specimens towards time
delay and mechanical stress caused only small changes to
the parameters, as visualised in the Bland-Altman-Plots.
However, the seemingly simple question whether the plot-
ted differences may be considered as “same or different”
cannot be answered by a universally accepted formula. The
interpretation of bare values actually depends on the overall
clinical context and many factors more.
The definition of “analytical validity” of the laboratory
test itself also deals with this challenge and provides
guidance for our dilemma. Definitions and margins
Fig. 5 Potassium (Unit: mmol/l). Bland-Altman plots for selected
biomarkers. The difference in measurements is plotted against the
average value of both associated measurements. The margins of
accuracy as given by the Rili-BAEK are drawn as sloping lines.
Agreement is high. Variations are random and no systemical bias
through treatment can be detected. Inaccuracy is well within the
limits of the Rili-BAEK and within tolerance of clinical interpretation
Fig. 6 Free Haemoglobin in Lithium-Heparin preserved Serum (Unit:
mg/l). Bland-Altman plots for selected biomarkers. The difference in
measurements is plotted against the average value of both associated
measurements. The margins of accuracy as given by the Rili-BAEK are
drawn as sloping lines. Agreement is high. Variations are random and
no systemical bias through treatment can be detected. Inaccuracy is
well within the limits of the Rili-BAEK and within tolerance of clinical
interpretation
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derive from technical aspects. They are generally ac-
cepted and uncoupled from subjective interpretation.
Even more so, they are given at a level of precision that
guarantees a reliable foundation for the diagnostic
process in general. Stringent quality control is
mandatory and defines clear margins for the accuracy of
analytical testing for each biomarker (Rili-BAEK) [15].
As a consequence it has to be postulated, that test
results with differences between them that lie within
these limits of test accuracy must be accepted as equal –
technically and clinically.
Within our data set the differences between treatment
groups generally lie within those margins of test accuracy.
Therefore results after prehospital treatment can be consid-
ered as clinically equal to those from immediate analysis.
The pre-analytical validity is given under conditions of a
worst-case scenario and therefore we postulate even smaller
inaccuracies under average mission circumstances in
Germany. Stability is given in all types of syringes. It is
demonstrated for cell counts, coagulation profiles, electro-
lyte levels and protein serum biomarkers. Our assortment
of tests represents some of the most relevant biomarkers in
emergency medicine and covers a wide range of disorders.
Haemolysis may interfere with chromagen tests, but
has been ruled out as a confounder by stable results for
alpha-HBDH and free haemoglobin during our experi-
ments [16, 17].
These findings are in accordance with previous studies
of pre-analytical stability of biomarkers in other surround-
ings. Troponin shows preanalytical validity in a variety of
maltreatment scenarios such as prolonged or sub-par stor-
age and repeated freeze-thaw cycles [18–20]. However,
troponin is a protein of limited metabolism within the
confinements of a blood sample and results may vary with
biomarkers of different biological properties.
Rotational thromboelastometry for example represents
a multifactorial functional test that is highly susceptible
to mechanical interference during analysis, and has been
shown to be subject to pre-analytical influences as well.
Transport of samples through pneumatic tube systems
led to statistically significant alterations of test results.
However, those changes were all within limits of what
the investigators defined as clinical irrelevance [21, 22].
Furthermore, some biomarkers need to be excluded
from analysis owing to biophysical considerations. Vola-
tile solubles such as oxygen and carbon dioxide will
rapidly alter their concentrations with clinical relevance
only minutes after sampling [23, 24].
In the end the clinical relevance of our study derives
from three points. 1. Our analysis brings alterations into
the accepted context of analytical accuracy as outlined
by the quality-assurance guidelines of the “Rili-BAEK”.
2. Treatment of samples represents a worst-case scenario
and suggests less error with normal treatment. 3. Our
choice of parameters reflects on relevance to emergency
medicine and excludes those a priori unsuitable due to
biophysical reasons.
Naturally there are some limitations to our study. As a
first, our specific scenario to test sample integrity repre-
sents only one combination of stressors out of many
thinkable. Our main focus lay on time delay and mech-
anical forces as possible factors of interference. However,
other external circumstances may influence preanalytical
stability as well such as subpar conditions for blood
sampling itself, extreme variations in temperature and
exposure to solar radiation. As pre-hospital emergency
medicine regularly takes place in an improvised outdoor
environment, these influences should be considered and
investigated in future studies. However, our study also
demonstrates, that low-tech solutions such as the use of
a cooler-box for sample storage can substantially limit
the impact of environmental elements.
Secondly, we have to admit that specimen treatment
might differ in nuances from ride to ride – in spite of all
steps taken to provide for reproducibility. However,
these limitations seem agreeable when compared to the
alternative of–highly standardizable, but totally artifi-
cial–mechanical stress generated by vibrating devices in-
side a laboratory.
Thirdly, our exposition scenario is aligned towards
transportation times found in the well-developed EMS-
infrastructure of a densely-populated country. It does
not cover very long sample transportation times beyond
60 min as they might be found in geographically challen-
ging settings or under conditions of limited health-care
infrastructure [25].
As a forth, we can only draw conclusions from param-
eters within the range of our test samples. While it is
biologically unlikely that extremely high or low concen-
trations of biomarkers will have different reactions to
our scenario, the absence of extreme values in our data
set does not allow anything but speculation for such
outliers.
Finally, our investigation focused on a selection of
parameters and methods of analysis and we can only
provide data for those within this collection.
Conclusion
Prehospital emergency medicine offers the possibility to
sample blood in the early stages of acute illness. Our study
demonstrates the pre-analytical stability and validity of
samples of such origin even after time delay and transport
outside of the hospital. The data set includes markers of
myocardial ischemia such as troponin and creatine kinase,
next to blood cells, electrolytes and coagulation profiles.
Keeping in mind the limitations of this investigation, it
seems worthwhile to investigate through future studies,
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the possible benefits to patient outcome deriving from
out-of-hospital blood sampling.
Additional files
Additional file 1: Figure S1. Leukocytes (Unit: 109/l). Bland-Altman
plots for selected biomarkers. The difference in measurements is plotted
against the average value of both associated measurements. The margins
of accuracy as given by the Rili-BAEK are drawn as sloping lines.
Agreement is high. Variations are random and no systemical bias through
treatment can be detected. Inaccuracy is well within the limits of the
Rili-BAEK and within tolerance of clinical interpretation. (PDF 37 kb)
Additional file 2: Figure S2. INR (Unit: not applicable). Bland-Altman
plots for selected biomarkers. The difference in measurements is plotted
against the average value of both associated measurements. The margins
of accuracy as given by the Rili-BAEK are drawn as sloping lines.
Agreement is high. Variations are random and no systemical bias through
treatment can be detected. Inaccuracy is well within the limits of the
Rili-BAEK and within tolerance of clinical interpretation. (PDF 36 kb)
Additional file 3: Figure S3. Creatin Kinase in serum with clotting
activator (Unit: U/l). Bland-Altman plots for selected biomarkers. The
difference in measurements is plotted against the average value of both
associated measurements. The margins of accuracy as given by the
Rili-BAEK are drawn as sloping lines. Agreement is high. Variations are
random and no systemical bias through treatment can be detected.
Inaccuracy is well within the limits of the Rili-BAEK and within tolerance
of clinical interpretation. (PDF 63 kb)
Additional file 4: Figure S4. Creatin Kinase in Lithium-Heparin preserved
serum (Unit: U/l). Bland-Altman plots for selected biomarkers. The difference
in measurements is plotted against the average value of both associated
measurements. The margins of accuracy as given by the Rili-BAEK are drawn
as sloping lines. Agreement is high. Variations are random and no systemical
bias through treatment can be detected. Inaccuracy is well within the limits
of the Rili-BAEK and within tolerance of clinical interpretation. (PDF 94 kb)
Additional file 5: Figure S5. Creatinine (Unit: mg/dl). Bland-Altman
plots for selected biomarkers. The difference in measurements is plotted
against the average value of both associated measurements. The margins
of accuracy as given by the Rili-BAEK are drawn as sloping lines.
Agreement is high. Variations are random and no systemical bias through
treatment can be detected. Inaccuracy is well within the limits of the
Rili-BAEK and within tolerance of clinical interpretation. (PDF 154 kb)
Additional file 6: Figure S6. Free Haemoglobin in serum with clotting
activator (Unit: mg/l). Bland-Altman plots for selected biomarkers. The
difference in measurements is plotted against the average value of both
associated measurements. The margins of accuracy as given by the
Rili-BAEK are drawn as sloping lines. Agreement is high. Variations are
random and no systemical bias through treatment can be detected.
Inaccuracy is well within the limits of the Rili-BAEK and within tolerance
of clinical interpretation. (PDF 286 kb)
Additional file 7: Figure S7. Alpha-HBDH in serum with clotting
activator (Unit: U/l) - Two outlying sample pairs have been excluded from
the plot for reasons of better graphical display (No. 1: Native: 1532;
Mechanic: 1529; No. 2: Native 357: Mechanic: 135). Bland-Altman plots for
selected biomarkers. The difference in measurements is plotted against
the average value of both associated measurements. The margins of
accuracy as given by the Rili-BAEK are drawn as sloping lines. Agreement
is high. Variations are random and no systemical bias through treatment
can be detected. Inaccuracy is well within the limits of the Rili-BAEK and
within tolerance of clinical interpretation. (PDF 566 kb)
Additional file 8: Figure S8. Alpha-HBDH in Lithium-Heparin preserved
serum (Unit: U/l)–One outlying sample pair has been excluded from the
plot for reasons of better graphical display (Native: 1526; Mechanic: 1534).
Bland-Altman plots for selected biomarkers. The difference in measurements
is plotted against the average value of both associated measurements. The
margins of accuracy as given by the Rili-BAEK are drawn as sloping lines.
Agreement is high. Variations are random and no systemical bias through
treatment can be detected. Inaccuracy is well within the limits of the
Rili-BAEK and within tolerance of clinical interpretation. (PDF 38 kb)
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